Keymed Biosciences Inc. (2162.HK)

HKD 48.0

(7.5%)

Long Term Debt Summary of Keymed Biosciences Inc.

Keymed Biosciences Inc.'s latest annual long term debt in 2023 was 353.45 Million CNY , up 610.78% from previous year.
Keymed Biosciences Inc.'s latest quarterly long term debt in 2024 Q1 was 348.64 Million CNY , up 5.07% from previous quarter.
Keymed Biosciences Inc. reported annual long term debt of 49.72 Million CNY in 2022, up 84.28% from previous year.
Keymed Biosciences Inc. reported annual long term debt of 26.98 Million CNY in 2021, up 32.84% from previous year.
Keymed Biosciences Inc. reported quarterly long term debt of 348.64 Million CNY for 2024 Q1, up 5.07% from previous quarter.
Keymed Biosciences Inc. reported quarterly long term debt of 353.45 Million CNY for 2023 Q3, up 17.19% from previous quarter.

Annual Long Term Debt Chart of Keymed Biosciences Inc. (2023 - 2019)

Historical Annual Long Term Debt of Keymed Biosciences Inc. (2023 - 2019)

Year	Long Term Debt	Long Term Debt Growth
2023	353.45 Million CNY	610.78%
2022	49.72 Million CNY	84.28%
2021	26.98 Million CNY	32.84%
2020	20.31 Million CNY	-16.3%
2019	24.27 Million CNY	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q2	348.64 Million CNY	0.0%
2024 Q1	348.64 Million CNY	5.07%
2023 Q3	353.45 Million CNY	17.19%
2023 FY	353.45 Million CNY	610.78%
2023 Q2	301.61 Million CNY	0.0%
2023 Q4	353.45 Million CNY	0.0%
2023 Q1	301.61 Million CNY	506.53%
2022 Q2	37.47 Million CNY	0.0%
2022 Q1	37.47 Million CNY	38.86%
2022 FY	49.72 Million CNY	84.28%
2022 Q4	49.72 Million CNY	0.0%
2022 Q3	49.72 Million CNY	32.71%
2021 FY	26.98 Million CNY	32.84%
2021 Q4	26.98 Million CNY	0.0%
2021 Q3	26.98 Million CNY	16.85%
2021 Q2	23.09 Million CNY	-99.59%
2021 Q1	5.6 Billion CNY	27499.44%
2020 FY	20.31 Million CNY	-16.3%
2020 Q4	20.31 Million CNY	-98.56%
2020 Q3	1.4 Billion CNY	0.0%
2020 Q1	- CNY	0.0%
2019 FY	24.27 Million CNY	0.0%

Peer Long Term Debt Comparison of Keymed Biosciences Inc.

Name	Long Term Debt	Long Term Debt Difference
Uni-Bio Science Group Limited	30.61 Million HKD	-1054.635%
CK Life Sciences Int'l., (Holdings) Inc.	4.27 Billion HKD	91.728%